0002076816-25-000001.txt : 20250807 0002076816-25-000001.hdr.sgml : 20250807 20250807170203 ACCESSION NUMBER: 0002076816-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20250807 DATE AS OF CHANGE: 20250807 EFFECTIVENESS DATE: 20250807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Red Cell Incubation Fund II, L.P. CENTRAL INDEX KEY: 0002076816 ORGANIZATION NAME: EIN: 334640034 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554057 FILM NUMBER: 251195180 BUSINESS ADDRESS: STREET 1: 1800 TYSONS BLVD, SUITE 900 CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 650-843-5000 MAIL ADDRESS: STREET 1: 1800 TYSONS BLVD, SUITE 900 CITY: MCLEAN STATE: VA ZIP: 22102 D 1 primary_doc.xml X0708 D LIVE 0002076816 Red Cell Incubation Fund II, L.P. 1800 TYSONS BLVD, SUITE 900 MCLEAN VA VIRGINIA 22102 650-843-5000 DELAWARE None None Limited Partnership true 2025 N/A Red Cell Incubation II GP, LLC 1800 Tysons Boulevard, Suite 900 McLean VA VIRGINIA 22102 Director General Partner of the Issuer N/A Red Cell Partners, LLC 1800 Tysons Boulevard, Suite 900 McLean VA VIRGINIA 22102 Director Manager of the General Partner of the Issuer Grant Verstandig 1800 Tysons Boulevard, Suite 900 McLean VA VIRGINIA 22102 Director Manager of the Manager of the General Partner of the Issuer Roger Ferguson 1800 Tysons Boulevard, Suite 900 McLean VA VIRGINIA 22102 Director Manager of the Manager of the General Partner of the Issuer Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.7 false true false true false 0 Park Lane IBS, LLC None Stonehaven, LLC 118913 600 Fifth Avenue 2nd Floor New York NY NEW YORK 10020 All States false 750000000 0 750000000 false 0 0 0 The broker will be entitled to certain scheduled fees payable by the issuer. 0 The General Partner (or the Management Company) is entitled to a management fee payable by the Issuer. false Red Cell Incubation Fund II, L.P. /s/ John Tiernan John Tiernan President of the General Partner of the Issuer 2025-08-07